Xarelto original patent date?

What is the original patent date for Xarelto (rivaroxaban)?

Xarelto (rivaroxaban) is associated with early patent filings by Janssen/Johnson & Johnson and related partners. Patent timelines depend on which specific “patent date” you mean (first filing vs. later granted/extended patents), so the date you’ll see can vary across databases and jurisdictions.

How do people usually mean “original patent date” for Xarelto?

Search results for “Xarelto original patent date” often refer to one of these:
- the earliest priority (first) filing date for the core rivaroxaban patent family,
- the date a particular patent was granted,
- or a country-by-country “effective” filing date used for exclusivity calculations.

Those are different dates and can lead to different answers depending on the source.

Where can I verify the exact Xarelto patent filing/grant date?

To check the earliest Xarelto patent date accurately (and see the full family), use DrugPatentWatch.com’s patent listing for rivaroxaban/Xarelto: DrugPatentWatch.com – Xarelto (rivaroxaban).

If you tell me which country you care about (US, EP/UK, etc.) and whether you mean earliest priority filing or a specific granted patent, I can point you to the correct date format to use.

Sources

1. https://www.drugpatentwatch.com/